Chloroacetic anhydride → (S)-8-bromo-1-(5-chloromethyl-1,2,4-oxadiazol-3-yl)-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one
Reaktionsgleichung
[Br:1][C:2]1[C:7]2[C:8](=[O:22])[N:9]3[CH2:21][CH2:20][C@H:10]3[C:11]3[N:12]([CH:13]=[N:14][C:15]=3[C:16](=[N:18][OH:19])[NH2:17])[C:6]=2[CH:5]=[CH:4][CH:3]=1.[Cl:23][CH2:24][C:25](OC(=O)CCl)=O>CN(C)C=O>[Br:1][C:2]1[C:7]2[C:8](=[O:22])[N:9]3[CH2:21][CH2:20][C@H:10]3[C:11]3[N:12]([CH:13]=[N:14][C:15]=3[C:16]3[N:17]=[C:25]([CH2:24][Cl:23])[O:19][N:18]=3)[C:6]=2[CH:5]=[CH:4][CH:3]=1Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
7 g (19.3 mmol) of (S)-8-bromo-9-oxo-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]-benzodiazepine-1-carboxamidoxime were stirred with 3.8 g (22.2 mmol) of chloroacetic anhydride in 50 ml of N,N-dimethylformamide at room temperature for 1 hour and at 105° for 2 hours. After evaporating the reaction mixture the residue was dissolved in methylene chloride and the solution was washed with saturated sodium bicarbonate solution. The organic phase was dried over magnesium sulfate and concentrated. After recrystallizing the residue from methanol there were obtained 5.3 g (65%) of (S)-8-bromo-1-(5-chloromethyl-1,2,4-oxadiazol-3-yl)-12,12a-dihydro-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one of m.p. 210°-211°.
Aufarbeitung
- customAfter evaporating the reaction mixture the residue
- dissolutionwas dissolved in methylene chloride
- washthe solution was washed with saturated sodium bicarbonate solution
- dry with materialThe organic phase was dried over magnesium sulfate
- concentrationconcentrated
- customAfter recrystallizing the residue from methanol
Quellen und Nachweise
- ORD-Eintrag
- ord-eb49f4a982d24f27b5f33de67846e91b
- Quelldatensatz
- uspto-grants-1997_09
- Patentnummer
- US05665718
Notizen zur Reaktion
Wird geladen…